Lv21
130 积分 2021-11-02 加入
Panitumumab the first fully human monoclonal antibody: from the bench to the clinic
3小时前
已完结
Blockade of EGFR and MEK intercepts heterogeneous mechanisms of acquired resistance to anti-EGFR therapies in colorectal cancer
4小时前
已完结
Trends in the drug target landscape for autoimmune diseases
25天前
已完结
The PD-1 expression balance between effector and regulatory T cells predicts the clinical efficacy of PD-1 blockade therapies
6个月前
已完结
TL1A inhibition for inflammatory bowel disease treatment: From inflammation to fibrosis
7个月前
已完结
Contribution of OX40/OX40 ligand interaction to the pathogenesis of rheumatoid arthritis
9个月前
已完结
Blockade of OX40/OX40L signaling using anti-OX40L alleviates murine lupus nephritis
9个月前
已完结
Non-clinical pharmacology and toxicology studies of bevacizumab biosimilar LY01008
9个月前
已完结
IL-12 and IL-23 pathway inhibition in inflammatory bowel disease
10个月前
已完结
皖公网安备34019202002308
